ChemRar High-Tech Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10656
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ロシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ChemRar High-Tech Center (CHTC) is a developer of drugs for life-threatening diseases. The company offers drugs for the treatment of cancer, central nervous system, infectious, metabolic and cardiovascular diseases. It also offers pre-clinical and clinical research of new molecules including screening and identification of the important biological targets for new molecules, synthesis and research of new molecules, and manufacturing. CHTC also invests in companies with drug candidates in early development stage. The company serves its clients in Japan and Russia. CHTC is headquartered in Khimki, Russia.

ChemRar High-Tech Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ChemRar High-Tech Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ChemRar High-Tech Center, Medical Devices Deals, 2012 to YTD 2018 9
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
ChemDiv Enters into Co-Development Agreement with Context Therapeutics and Torrey Pines Investment 12
Regen BioPharma Enters into Agreement with ChemDiv 13
Janssen Research & Development Enters into Agreement with ChemDiv 14
ChemDiv, Torrey Pines Investment and DZNE Enter into Research Agreement 15
ChemDiv and Insilico Medicine Enter into Collaboration Agreement 16
National Immunobiological Forms Joint Venture with ChemRar HTC 17
ChemDiv Enters into Agreement with Cystic Fibrosis Foundation Therapeutics 18
ChemRar High Tech Center Enters into Agreement with Lancet to Develop Novel Drugs in Russia 19
ChemDiv Enters into R&D Agreement with UCSD, MIPT and SatRx 20
Dompe Farmaceutici Enters Into Co-Development Agreement With SatRx For Reparixin 21
MIPT, Wi2 And ChemDiv Research Institute Partner To Develop Therapeutics For Human Health 22
Coare Biotech Enters Into Agreement With ChemDiv To Offer Gene-To-Clinic Services 23
ChemDiv Research Institute Expands Co-Development Agreement with Abbott Labs 24
Licensing Agreements 25
Pfizer Enters Into Licensing Agreement With SatRx For PF-00734200 25
NewVac Enters Into Licensing Agreement With Janssen For Quisinostat 26
Equity Offering 27
Viriom Raises USD2.35 Million in Private Placement of Shares 27
ChemRar High-Tech Center – Key Competitors 28
ChemRar High-Tech Center – Key Employees 29
ChemRar High-Tech Center – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Key Facts 2
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ChemRar High-Tech Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ChemRar High-Tech Center, Deals By Therapy Area, 2012 to YTD 2018 8
ChemRar High-Tech Center, Medical Devices Deals, 2012 to YTD 2018 9
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ChemDiv Enters into Co-Development Agreement with Context Therapeutics and Torrey Pines Investment 12
Regen BioPharma Enters into Agreement with ChemDiv 13
Janssen Research & Development Enters into Agreement with ChemDiv 14
ChemDiv, Torrey Pines Investment and DZNE Enter into Research Agreement 15
ChemDiv and Insilico Medicine Enter into Collaboration Agreement 16
National Immunobiological Forms Joint Venture with ChemRar HTC 17
ChemDiv Enters into Agreement with Cystic Fibrosis Foundation Therapeutics 18
ChemRar High Tech Center Enters into Agreement with Lancet to Develop Novel Drugs in Russia 19
ChemDiv Enters into R&D Agreement with UCSD, MIPT and SatRx 20
Dompe Farmaceutici Enters Into Co-Development Agreement With SatRx For Reparixin 21
MIPT, Wi2 And ChemDiv Research Institute Partner To Develop Therapeutics For Human Health 22
Coare Biotech Enters Into Agreement With ChemDiv To Offer Gene-To-Clinic Services 23
ChemDiv Research Institute Expands Co-Development Agreement with Abbott Labs 24
Pfizer Enters Into Licensing Agreement With SatRx For PF-00734200 25
NewVac Enters Into Licensing Agreement With Janssen For Quisinostat 26
Viriom Raises USD2.35 Million in Private Placement of Shares 27
ChemRar High-Tech Center, Key Competitors 28
ChemRar High-Tech Center, Key Employees 29
ChemRar High-Tech Center, Subsidiaries 30
ChemRar High-Tech Center, Joint Venture 31

List of Figures
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ChemRar High-Tech Center, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ChemRar High-Tech Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Svelte Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Svelte Medical Systems Inc (Svelte) is a medical device company that manufactures and designs balloon expandable stents. The company offers products such as balloon expandable stents, svelte acrobat, and drug eluting stents, among others. Its svelte acrobat is a stent-on-a-wire bare metal co …
  • HTC Corporation:企業のM&A・事業提携・投資動向
    HTC Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HTC Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Alder Biopharmaceuticals Inc (ALDR):企業の財務・戦略的SWOT分析
    Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Southern Co (SO):企業の財務・戦略的SWOT分析
    Southern Co (SO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cajun Industries, LLC:企業の戦略的SWOT分析
    Cajun Industries, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Chiesi Farmaceutici SpA:企業の戦略的SWOT分析
    Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Dova Pharmaceuticals Inc (DOVA)-製薬・医療分野:企業M&A・提携分析
    Summary Dova Pharmaceuticals Inc (Dova) is a clinical-stage pharmaceutical company that develops therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (AVA), a novel, oral thrombopoietin receptor agonist, is under development for the treatment of thrombocytopenia …
  • Seattle Genetics Inc (SGEN):企業の財務・戦略的SWOT分析
    Seattle Genetics Inc (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • GS Yuasa Corporation (6674):企業の財務・戦略的SWOT分析
    GS Yuasa Corporation (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Bolu Cimento Sanayii AS:企業の戦略・SWOT・財務情報
    Bolu Cimento Sanayii AS - Strategy, SWOT and Corporate Finance Report Summary Bolu Cimento Sanayii AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Joslin Diabetes Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Joslin Diabetes Center (Joslin) is a healthcare service provider that offers diabetes treatment, research and education services. The center provides services such as weight management programs, pregnancy program, eye care, diabetes prevention, research, diabetes patient education, adult dia …
  • NanoString Technologies Inc (NSTG):製薬・医療:M&Aディール及び事業提携情報
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • Medicontur Medical Engineering Ltd:製品パイプライン分析
    Summary Medicontur Medical Engineering Ltd (Medicontur) is a developer and manufacturer of intraocular lenses. The company offers hydrophilic and hydrophobic model lenses including monofocal aspheric, toric, and standard monofocal aspheric lenses; preloaded capsular tension rings; PMMA implants; inj …
  • A.G.Barr p.l.c.:企業の戦略・SWOT・財務情報
    A.G.Barr p.l.c. - Strategy, SWOT and Corporate Finance Report Summary A.G.Barr p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Torrent Pharmaceuticals Ltd (TORNTPHARM):企業の財務・戦略的SWOT分析
    Torrent Pharmaceuticals Ltd (TORNTPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Channel Four Telivision Corp:企業の戦略的SWOT分析
    Channel Four Telivision Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Respira Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Respira Therapeutics Inc (Respira) is a pharmaceutical development company that develops dry powder inhaler technologies. The company develops Inhaler technologies to enable targeted lung delivery of drugs to treat pulmonary diseases. It develops products used for the treatment of pulmonary …
  • Selex Gruppo Commerciale S.p.A.:企業の戦略・SWOT・財務情報
    Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Avanti Energy Inc (AVN):企業の財務・戦略的SWOT分析
    Summary Avanti Energy Inc (Avanti Energy), formerly known as Overlord Capital Ltd is an oil and gas exploration and production company. The company acquires, explores, and develops gas reserves in Central Italy. It re-develops the existing oil and gas reserves. Avanti Energy owns the Colle Santo gas …
  • Iberia Lineas Aereas De Espana, Sa:企業の戦略・SWOT・財務分析
    Iberia Lineas Aereas De Espana, Sa - Strategy, SWOT and Corporate Finance Report Summary Iberia Lineas Aereas De Espana, Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆